169 related articles for article (PubMed ID: 38549232)
1. Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver.
Di Cola S; Khan S; Lapenna L; Merli M
Expert Opin Emerg Drugs; 2024 Jun; 29(2):81-91. PubMed ID: 38549232
[TBL] [Abstract][Full Text] [Related]
2. The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease.
Dos Santos ALS; Anastácio LR
Expert Rev Gastroenterol Hepatol; 2021 Feb; 15(2):181-194. PubMed ID: 32993404
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia in cirrhosis: from pathogenesis to interventions.
Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia impairs prognosis of patients with liver cirrhosis.
Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
[TBL] [Abstract][Full Text] [Related]
5. [Protein catabolism and malnutrition in liver cirrhosis - impact of oral nutritional therapy].
Norman K; Valentini L; Lochs H; Pirlich M
Z Gastroenterol; 2010 Jul; 48(7):763-70. PubMed ID: 20607635
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.
Kitajima Y; Takahashi H; Akiyama T; Murayama K; Iwane S; Kuwashiro T; Tanaka K; Kawazoe S; Ono N; Eguchi T; Anzai K; Eguchi Y
J Gastroenterol; 2018 Mar; 53(3):427-437. PubMed ID: 28741271
[TBL] [Abstract][Full Text] [Related]
7. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.
Bunchorntavakul C; Reddy KR
Aliment Pharmacol Ther; 2020 Jan; 51(1):64-77. PubMed ID: 31701570
[TBL] [Abstract][Full Text] [Related]
8. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia.
Mohta S; Anand A; Sharma S; Qamar S; Agarwal S; Gunjan D; Singh N; Madhusudhan KS; Pandey RM; Saraya A
Hepatol Int; 2022 Jun; 16(3):680-690. PubMed ID: 35469091
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial.
Hey P; Hoermann R; Sinclair M; Chapman B; Testro A; Apostolov R; Angus P; Gow P
Aliment Pharmacol Ther; 2024 Apr; 59(8):941-952. PubMed ID: 38404263
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.
Hiraoka A; Michitaka K; Kiguchi D; Izumoto H; Ueki H; Kaneto M; Kitahata S; Aibiki T; Okudaira T; Tomida H; Miyamoto Y; Yamago H; Suga Y; Iwasaki R; Mori K; Miyata H; Tsubouchi E; Kishida M; Ninomiya T; Kohgami S; Hirooka M; Tokumoto Y; Abe M; Matsuura B; Hiasa Y
Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1416-1423. PubMed ID: 29016470
[TBL] [Abstract][Full Text] [Related]
11. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.
Sinclair M; Gow PJ; Grossmann M; Angus PW
Aliment Pharmacol Ther; 2016 Apr; 43(7):765-77. PubMed ID: 26847265
[TBL] [Abstract][Full Text] [Related]
12. Effect of branched-chain amino acid supplementation and exercise on quadriceps muscle quantity and quality in patients with cirrhosis as assessed by ultrasonography: A randomized controlled trial.
Sobhy E; Kamal MM; Saad Y; Saleh DA; Elgohary R; Hassan MS
Clin Nutr ESPEN; 2024 Jun; 61():108-118. PubMed ID: 38777422
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of sarcopenia assessment in patients with liver cirrhosis.
Marasco G; Dajti E; Ravaioli F; Brocchi S; Rossini B; Alemanni LV; Peta G; Bartalena L; Golfieri R; Festi D; Colecchia A; Renzulli M
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):377-388. PubMed ID: 33196344
[No Abstract] [Full Text] [Related]
14. Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
Hernández-Conde M; Llop E; Gómez-Pimpollo L; Fernández Carrillo C; Rodríguez L; Van Den Brule E; Perelló C; López-Gómez M; Abad J; Martínez-Porras JL; Fernández-Puga N; Ferre C; Trapero M; Fraga E; Calleja JL
Am J Gastroenterol; 2021 Nov; 116(11):2241-2249. PubMed ID: 34074812
[TBL] [Abstract][Full Text] [Related]
15. Nutrition and exercise in the management of liver cirrhosis.
Toshikuni N; Arisawa T; Tsutsumi M
World J Gastroenterol; 2014 Jun; 20(23):7286-97. PubMed ID: 24966599
[TBL] [Abstract][Full Text] [Related]
16. Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
Hiraoka A; Kiguchi D; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):878-884. PubMed ID: 31150367
[TBL] [Abstract][Full Text] [Related]
17. Nutraceuticals for the treatment of sarcopenia in chronic liver disease.
Hey P; Gow P; Testro AG; Apostolov R; Chapman B; Sinclair M
Clin Nutr ESPEN; 2021 Feb; 41():13-22. PubMed ID: 33487256
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?
Buchard B; Boirie Y; Cassagnes L; Lamblin G; Coilly A; Abergel A
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31936597
[TBL] [Abstract][Full Text] [Related]
19. Cause and management of muscle wasting in chronic liver disease.
Dasarathy S
Curr Opin Gastroenterol; 2016 May; 32(3):159-65. PubMed ID: 26974417
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
Moriwaki H; Miwa Y; Tajika M; Kato M; Fukushima H; Shiraki M
Biochem Biophys Res Commun; 2004 Jan; 313(2):405-9. PubMed ID: 14684176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
